Jerman

Index
Globenewswire

RIB Achieves Dual Milestone: Industry-Led Product Enhancements and Public-Sector ERP Recognition

Globenewswire

European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU

Globenewswire

Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development

Globenewswire

Sigenergy Unveils SigenMate 2700 Ultra: a Future-Ready AI-Powered Plug & Play Home Energy System

Globenewswire

Krannich Solar adds Sigenergy to its product range

Globenewswire

Chinese inventors Xie Yinghao and Yu Haijun secure dual win at the European Inventor Award 2026 for smart battery recycling

Globenewswire

Surventis launches as an independent global leader in automotive coatings and surface treatment

Globenewswire

Mavenir Meraih Penghargaan Mitra Terbaik Tahun Ini dari Deutsche Telekom untuk Inovasi Jaringan Terbaik

Globenewswire

Mavenir Wins Deutsche Telekom's Partner of the Year Award for Best Network Innovation

Globenewswire

MOVA LumeGret Debuts S4800 and Expands Residential Energy Portfolio at Intersolar Europe 2026

Globenewswire

Sigenergy Secures Over 20 GWh in Global Energy Storage Agreements at Intersolar Europe 2026

Globenewswire

Sigenergy Hosts Media Exclusive Event for SigenMate 2700 Ultra, Plug & Play Energy System, at Intersolar Europe 2026

Globenewswire

EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis

Globenewswire

Sigenergy Unveils SigenStor Neo and Complete Home Energy Ecosystem at Intersolar Europe 2026: Reimagining Sustainable Living Through AI

Globenewswire

Sigenergy Advances "AI in All" Strategy and Honors Global Partners at Intersolar 2026

Globenewswire

Sigenergy Showcases Full-Scenario Energy Innovations at Intersolar Europe 2026, Accelerating "AI in All" Strategy

Globenewswire

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Globenewswire

Mavenir Menjadi Vendor Perangkat Lunak Jaringan Besar Pertama yang Menerima Sertifikasi Fungsi Jaringan 5G Packet Core dalam Skema BSI NESAS Jerman

Globenewswire

Mavenir First Major Network Software Vendor to Receive 5G Packet Core Network Function Certification Under Germany's BSI NESAS Scheme

Globenewswire

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Globenewswire

GetYourGuide unveils summer 2026's three defining travel trends

Globenewswire

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

Globenewswire

CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU

Globenewswire

China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis

Globenewswire

Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026